Login to Your Account



NeuroSearch Pockets €32M Plus in Discovery Deal with Janssen

By Cormac Sheridan


Wednesday, August 19, 2009

NeuroSearch A/S will bank as much as €32 million (US$45.1 million) in guaranteed funding over the next three years on the strength of a new drug discovery and development alliance in central nervous system disease with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson Co., of New Brunswick, N.J. (BioWorld International)

 

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription